Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

NCT02534649 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT02534649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02534649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials
Lead sponsor
Institut Bergonié
Phase
Not applicable
Overall status
Recruiting
Start date
December 31, 2015
Completion date
December 31, 2029
Enrollment
10,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancy, solid tumor